Browsing Category

Topics

In a regular blog series, Simon O’Neill, Diabetes UK’s Director of Health Intelligence and Professional Liaison, rounds up the latest diabetes news. This week Simon rounds up the latest technologies, medicines and treatments. Ultra Rapid Insulin Eli Lilly have announced that they are ending their licensing agreement for ultra-rapid-acting insulin BioChaperone Lispro. The company that developed this insulin,…